Ocugen (OCGN) Share-based Compensation (2014 - 2026)

Ocugen (OCGN) reported Share-based Compensation of $3.4 million for Q1 2026, up 80.27% on a YoY basis from $1.9 million in Q1 2025, and up 69.73% quarter-over-quarter from $2.0 million in Q4 2025.

Ocugen (OCGN) Share-based Compensation (2014 - 2026) Analysis & Trends

Ocugen has reported Share-based Compensation for 13 years, with the latest figure at $3.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 80.27% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (up 7.5% YoY), and the FY2025 full-year result was $7.7 million, up 3.77% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $3.4 million, up from $2.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $3.4 million in Q1 2026, with the low at $741000.0 in Q2 2025.
  • Historically, Share-based Compensation has averaged $2.2 million across 5 years, with a median of $2.0 million in 2025.
  • Annual changes were most pronounced in 2022 — Share-based Compensation surged 296.04% — and 2025, when it slumped 60.96%.
  • Ocugen's Share-based Compensation stood at $2.7 million in 2022, then sank by 35.46% to $1.7 million in 2023, then gained by 8.94% to $1.9 million in 2024, then gained by 6.72% to $2.0 million in 2025, then jumped by 69.73% to $3.4 million in 2026.
  • The last three Share-based Compensation figures came in at $3.4 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Ocugen 411.07 Mn 411.07 Mn - 3.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.40 Mn
Mar 31, 2026 3.40 Mn
Dec 31, 2025 2.00 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 1.98 Mn
Sep 30, 2025 1.98 Mn
Jun 30, 2025 741,000.00
Jun 30, 2025 741,000.00
Mar 31, 2025 1.89 Mn
Mar 31, 2025 1.89 Mn
Dec 31, 2024 1.88 Mn
Dec 31, 2024 1.88 Mn
Sep 30, 2024 1.89 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 1.90 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 1.76 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 1.72 Mn
Dec 31, 2023 1.72 Mn